Composition: Lisinopril IP 2.5 mg; Lisinopril IP 5 mg; Lowpril Lisinopril Dihydrate BP equivalent to Lisinopril Anhydrous 20 mg
Usage: Hypertension and heart failure; selected post-heart-attack patients
Category: Anti Hypertensive / Cardiac Drugs
Therapeutic category: ACE Inhibitor / Antihypertensive
SKU: Lisinopril Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Lisinopril Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Lisinopril Tablets are prescription angiotensin-converting enzyme (ACE) inhibitors used for high blood pressure and selected patients with heart failure. Lisinopril may also be prescribed after an acute myocardial infarction in eligible, clinically stable patients. The supplied formulations include Lisinopril IP 2.5 mg, Lisinopril IP 5 mg and Lowpril Lisinopril BP 20 mg (expressed as anhydrous lisinopril equivalent).
Manufacturer stated: Healthy Life Pharma Pvt. Ltd. Exporter stated: Healthy Inc. Verify facility credentials, registrations and supply terms before publication or procurement.
| Product name | Lisinopril Tablets |
|---|---|
| Brand | Lowpril (20 mg BP formulation) |
| IP composition | Each film-coated tablet contains Lisinopril IP 2.5 mg or 5 mg |
| BP composition | Each film-coated Lowpril tablet contains Lisinopril Dihydrate BP equivalent to Lisinopril Anhydrous 20 mg |
| Confirmed strengths | 2.5 mg / 5 mg / 20 mg |
| Dosage form | Film-coated oral tablet |
| Therapeutic class | ACE inhibitor / Antihypertensive / Cardiovascular agent |
| Uses | Hypertension, selected heart-failure regimens, and selected post-myocardial-infarction patients |
| SKU | Lisinopril Tablets |
| Packaging / shelf life | Confirm with the approved product label and stability data |
Film-coated lisinopril tablets require a validated formulation process to maintain consistent content uniformity, tablet hardness, disintegration and dissolution. Manufacturing methods may involve controlled blending, compression and film coating according to the registered formulation. Specific manufacturing equipment, excipients and production methods should be confirmed against site records before making public claims.
Typical finished-product controls include identification, assay, content uniformity, dissolution, related substances, microbial quality where applicable, and stability testing. Acceptance criteria depend on the relevant pharmacopoeial monograph and approved specifications. Batch-level Certificates of Analysis, GMP evidence and registration documents must be verified.
Lisinopril inhibits angiotensin-converting enzyme, reducing angiotensin II formation and aldosterone activity. This relaxes blood vessels, lowers blood pressure and can reduce cardiac workload.
It is not an antiarrhythmic drug and is not a substitute for emergency treatment of chest pain.
Prospective buyers may request product specifications, COA, applicable GMP documentation, stability information and regulatory dossier support, subject to availability and destination-country requirements. WHO-GMP, COPP, FSC and market authorization claims must be substantiated for the specific product and facility.
Q: Which strengths are specified?
A: Lisinopril IP 2.5 mg, Lisinopril IP 5 mg and Lowpril BP 20 mg equivalent to anhydrous lisinopril.
Q: Is Lowpril a different active ingredient?
A: No. The supplied Lowpril formulation contains lisinopril dihydrate equivalent to 20 mg anhydrous lisinopril.
Q: Can it be used during pregnancy?
A: No. Medicines acting on the renin–angiotensin system can harm or kill a developing fetus. Contact a healthcare professional promptly if pregnancy occurs.
Q: Does it require blood tests?
A: Kidney function and potassium are commonly monitored, especially after initiation or dose changes.
Take only as prescribed. The dose is individualized according to indication, blood pressure, kidney function, other medicines and patient characteristics. Lisinopril is generally taken orally once daily, with or without food, as directed by the approved label. Do not change the dose or stop treatment without medical advice. Kidney impairment can require dose adjustments.
Keep in the original labeled packaging, protected from moisture and excessive heat as directed by the approved market-specific label. The exact temperature limit and shelf life must be confirmed against registered stability data. Keep out of reach of children.